| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF823 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 SMAD1 SMAD2 SMAD3 SMAD5 SMAD9 | 3.50e-15 | 1459 | 151 | 43 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 TIPARP ZNF551 ZNF546 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 SMAD1 SMAD2 SMAD3 SMAD5 SMAD9 | 4.79e-15 | 1271 | 151 | 40 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF551 ZNF546 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 SMAD1 SMAD2 SMAD3 SMAD5 SMAD9 | 1.30e-14 | 1244 | 151 | 39 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF823 ZNF787 ZNF502 ZNF845 ZNF140 ZNF573 ZNF146 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF226 ZNF699 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 SMAD1 SMAD2 SMAD3 SMAD5 SMAD9 | 3.03e-14 | 1412 | 151 | 41 | GO:0000981 |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.33e-07 | 17 | 151 | 5 | GO:0070411 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 3.44e-05 | 9 | 151 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 8.87e-05 | 12 | 151 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.70e-04 | 3 | 151 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF845 ZBTB17 GLIS3 ZNF226 ZNF699 RLF ZNF836 ZNF341 ZNF808 GLIS1 SMAD1 SMAD2 SMAD3 | 3.76e-04 | 566 | 151 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | SMAD binding | 4.93e-04 | 86 | 151 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 5.60e-04 | 5 | 151 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.91e-04 | 140 | 151 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 7.41e-04 | 54 | 151 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 8.58e-04 | 326 | 151 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF845 ZBTB17 GLIS3 ZNF226 ZNF699 RLF ZNF836 ZNF808 GLIS1 SMAD1 SMAD2 SMAD3 | 1.15e-03 | 560 | 151 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | translation termination factor activity | 1.16e-03 | 7 | 151 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 1.16e-03 | 7 | 151 | 2 | GO:0003747 | |
| GeneOntologyMolecularFunction | histone kinase activity | 1.21e-03 | 28 | 151 | 3 | GO:0035173 | |
| GeneOntologyBiologicalProcess | Mullerian duct regression | 3.73e-06 | 5 | 150 | 3 | GO:0001880 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 5.25e-05 | 2 | 150 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 5.25e-05 | 2 | 150 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 5.25e-05 | 2 | 150 | 2 | GO:1904882 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 1.01e-09 | 8 | 151 | 5 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 4.50e-09 | 10 | 151 | 5 | GO:0071141 | |
| GeneOntologyCellularComponent | homomeric SMAD protein complex | 5.18e-05 | 2 | 151 | 2 | GO:0071142 | |
| GeneOntologyCellularComponent | megasporocyte nucleus | 5.18e-05 | 2 | 151 | 2 | GO:0043076 | |
| GeneOntologyCellularComponent | translation release factor complex | 1.55e-04 | 3 | 151 | 2 | GO:0018444 | |
| GeneOntologyCellularComponent | dynein complex | 6.25e-04 | 54 | 151 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.56e-04 | 25 | 151 | 3 | GO:0005858 | |
| Domain | - | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 1.05e-25 | 679 | 151 | 42 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 2.33e-25 | 693 | 151 | 42 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 2.47e-25 | 694 | 151 | 42 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 HELZ2 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 1.87e-24 | 775 | 151 | 43 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 HELZ2 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 2.08e-24 | 777 | 151 | 43 | PS00028 |
| Domain | Znf_C2H2-like | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 HELZ2 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 5.40e-24 | 796 | 151 | 43 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 HELZ2 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 9.73e-24 | 808 | 151 | 43 | SM00355 |
| Domain | Znf_C2H2 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 7.75e-23 | 805 | 151 | 42 | IPR007087 |
| Domain | zf-C2H2_6 | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF613 ZNF329 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 ZBTB49 ZNF836 ZNF852 ZFP64 ZNF808 ZNF420 ZNF701 ZNF761 | 8.61e-16 | 314 | 151 | 23 | PF13912 |
| Domain | KRAB | ZNF823 ZNF567 ZNF845 ZNF140 ZNF573 ZNF613 ZKSCAN7 ZNF226 ZNF699 ZNF181 ZNF440 ZNF551 ZNF546 ZNF630 ZNF836 ZNF852 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF471 | 1.45e-14 | 358 | 151 | 23 | PS50805 |
| Domain | KRAB | ZNF823 ZNF567 ZNF845 ZNF140 ZNF573 ZNF613 ZKSCAN7 ZNF226 ZNF699 ZNF181 ZNF440 ZNF551 ZNF546 ZNF630 ZNF836 ZNF852 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF471 | 1.45e-14 | 358 | 151 | 23 | PF01352 |
| Domain | KRAB | ZNF823 ZNF567 ZNF845 ZNF140 ZNF573 ZNF613 ZKSCAN7 ZNF226 ZNF699 ZNF181 ZNF440 ZNF551 ZNF546 ZNF630 ZNF836 ZNF852 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF471 | 2.77e-14 | 369 | 151 | 23 | SM00349 |
| Domain | KRAB | ZNF823 ZNF567 ZNF845 ZNF140 ZNF573 ZNF613 ZKSCAN7 ZNF226 ZNF699 ZNF181 ZNF440 ZNF551 ZNF546 ZNF630 ZNF836 ZNF852 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF471 | 2.93e-14 | 370 | 151 | 23 | IPR001909 |
| Domain | Dwarfin | 1.78e-09 | 8 | 151 | 5 | IPR013790 | |
| Domain | DWB | 1.78e-09 | 8 | 151 | 5 | SM00524 | |
| Domain | MH2 | 1.78e-09 | 8 | 151 | 5 | PS51076 | |
| Domain | MH1 | 1.78e-09 | 8 | 151 | 5 | PS51075 | |
| Domain | - | 1.78e-09 | 8 | 151 | 5 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.78e-09 | 8 | 151 | 5 | IPR013019 | |
| Domain | MH2 | 1.78e-09 | 8 | 151 | 5 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.78e-09 | 8 | 151 | 5 | IPR001132 | |
| Domain | MAD_homology1_Dwarfin-type | 2.45e-08 | 12 | 151 | 5 | IPR003619 | |
| Domain | DWA | 2.45e-08 | 12 | 151 | 5 | SM00523 | |
| Domain | MH1 | 2.45e-08 | 12 | 151 | 5 | PF03165 | |
| Domain | SMAD_dom-like | 1.31e-07 | 16 | 151 | 5 | IPR017855 | |
| Domain | - | 1.31e-07 | 16 | 151 | 5 | 2.60.200.10 | |
| Domain | SMAD_FHA_domain | 3.79e-06 | 52 | 151 | 6 | IPR008984 | |
| Domain | FAT | 1.02e-05 | 6 | 151 | 3 | PS51189 | |
| Domain | FATC | 1.02e-05 | 6 | 151 | 3 | PS51190 | |
| Domain | FAT | 1.02e-05 | 6 | 151 | 3 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.02e-05 | 6 | 151 | 3 | IPR003151 | |
| Domain | FATC_dom | 1.02e-05 | 6 | 151 | 3 | IPR003152 | |
| Domain | PIK_FAT | 1.02e-05 | 6 | 151 | 3 | IPR014009 | |
| Domain | FATC | 1.02e-05 | 6 | 151 | 3 | SM01343 | |
| Domain | - | 2.69e-04 | 16 | 151 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.69e-04 | 16 | 151 | 3 | SM00146 | |
| Domain | CABIT | 3.85e-04 | 4 | 151 | 2 | PF12736 | |
| Domain | CABIT_dom | 3.85e-04 | 4 | 151 | 2 | IPR025946 | |
| Domain | PI3/4_kinase_cat_dom | 3.87e-04 | 18 | 151 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.87e-04 | 18 | 151 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.87e-04 | 18 | 151 | 3 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.87e-04 | 18 | 151 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.87e-04 | 18 | 151 | 3 | PS00916 | |
| Domain | FATC | 6.39e-04 | 5 | 151 | 2 | PF02260 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.76e-03 | 8 | 151 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 1.76e-03 | 8 | 151 | 2 | PF03143 | |
| Domain | - | 2.22e-03 | 222 | 151 | 7 | 1.25.10.10 | |
| Domain | G_TR_CS | 2.25e-03 | 9 | 151 | 2 | IPR031157 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.80e-03 | 10 | 151 | 2 | IPR009001 | |
| Domain | WWE | 4.06e-03 | 12 | 151 | 2 | PS50918 | |
| Domain | WWE | 4.06e-03 | 12 | 151 | 2 | PF02825 | |
| Domain | WWE-dom | 4.06e-03 | 12 | 151 | 2 | IPR004170 | |
| Domain | Kinase-like_dom | 4.63e-03 | 542 | 151 | 11 | IPR011009 | |
| Domain | G_TR_1 | 4.78e-03 | 13 | 151 | 2 | PS00301 | |
| Domain | Dynein_HC_stalk | 5.54e-03 | 14 | 151 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.54e-03 | 14 | 151 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.54e-03 | 14 | 151 | 2 | PF08393 | |
| Domain | MT | 5.54e-03 | 14 | 151 | 2 | PF12777 | |
| Domain | DHC_fam | 6.36e-03 | 15 | 151 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 6.36e-03 | 15 | 151 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 6.36e-03 | 15 | 151 | 2 | PF03028 | |
| Domain | PI3/4_kinase_CS | 6.36e-03 | 15 | 151 | 2 | IPR018936 | |
| Domain | ARM-type_fold | 6.40e-03 | 339 | 151 | 8 | IPR016024 | |
| Domain | ARM-like | 6.46e-03 | 270 | 151 | 7 | IPR011989 | |
| Domain | HEAT | 6.87e-03 | 48 | 151 | 3 | PF02985 | |
| Domain | Globin-like | 7.23e-03 | 16 | 151 | 2 | IPR009050 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.29e-07 | 37 | 92 | 6 | M39506 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 2.09e-07 | 9 | 92 | 4 | M47844 | |
| Pathway | PID_ALK2_PATHWAY | 5.41e-07 | 11 | 92 | 4 | M203 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF567 ZNF140 ZNF573 ERCC3 ZNF613 ATR ZKSCAN7 ZNF226 ZNF699 ZNF440 ZNF551 ZNF546 FANCD2 CCNA1 ZNF70 ZNF420 ZNF701 ZNF761 ZNF528 ATM ZNF471 SMAD1 SMAD2 SMAD3 | 6.18e-06 | 1387 | 92 | 24 | M734 |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 9.24e-06 | 7 | 92 | 3 | M47845 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47847 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 2.03e-05 | 86 | 92 | 6 | M2642 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47822 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 2.38e-05 | 53 | 92 | 5 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.85e-05 | 55 | 92 | 5 | M39351 | |
| Pathway | BIOCARTA_G1_PATHWAY | 3.09e-05 | 28 | 92 | 4 | M648 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF823 ZNF845 ERCC3 ZKSCAN7 ZNF226 ZNF699 ZNF551 ZNF836 ZNF852 CCNA1 ZNF808 ZNF420 ATM SMAD1 SMAD2 SMAD3 | 3.32e-05 | 768 | 92 | 16 | MM14851 |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.02e-05 | 59 | 92 | 5 | M39886 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47848 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.67e-05 | 31 | 92 | 4 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.67e-05 | 31 | 92 | 4 | MM14789 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 7.34e-05 | 13 | 92 | 3 | M39378 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 7.35e-05 | 108 | 92 | 6 | M48078 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.20e-04 | 118 | 92 | 6 | MM15588 | |
| Pathway | WP_CELL_CYCLE | 1.32e-04 | 120 | 92 | 6 | M39650 | |
| Pathway | KEGG_CELL_CYCLE | 1.65e-04 | 125 | 92 | 6 | M7963 | |
| Pathway | WP_INTEGRATED_CANCER_PATHWAY | 2.65e-04 | 48 | 92 | 4 | M39628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 2.83e-04 | 20 | 92 | 3 | M47843 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 3.79e-04 | 22 | 92 | 3 | M9703 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 5.58e-04 | 25 | 92 | 3 | M39665 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION | 6.21e-04 | 6 | 92 | 2 | MM15419 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 6.21e-04 | 6 | 92 | 2 | MM14517 | |
| Pathway | PID_ALK1_PATHWAY | 6.27e-04 | 26 | 92 | 3 | M185 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.42e-04 | 161 | 92 | 6 | M27871 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 7.10e-04 | 62 | 92 | 4 | M27618 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE | 8.66e-04 | 7 | 92 | 2 | MM15333 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 8.66e-04 | 7 | 92 | 2 | M29623 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 8.66e-04 | 7 | 92 | 2 | MM15661 | |
| Pathway | PID_BARD1_PATHWAY | 8.69e-04 | 29 | 92 | 3 | M258 | |
| Pathway | BIOCARTA_G1_PATHWAY | 8.69e-04 | 29 | 92 | 3 | MM1364 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF823 ZNF845 ERCC3 ZKSCAN7 ZNF226 ZNF699 ZNF551 ZNF836 ZNF852 CCNA1 ZNF808 ZNF420 ATM SMAD1 SMAD2 SMAD3 | 8.71e-04 | 1022 | 92 | 16 | MM15436 |
| Pathway | BIOCARTA_PLK3_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M22021 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.15e-03 | 8 | 92 | 2 | M42528 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M47846 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 1.15e-03 | 8 | 92 | 2 | M27246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 1.47e-03 | 9 | 92 | 2 | M47586 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.55e-03 | 191 | 92 | 6 | MM15289 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 1.83e-03 | 10 | 92 | 2 | M47572 | |
| Pubmed | 1.54e-12 | 5 | 153 | 5 | 19819941 | ||
| Pubmed | 1.54e-12 | 5 | 153 | 5 | 25141865 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 9.22e-12 | 6 | 153 | 5 | 18952608 | |
| Pubmed | 9.22e-12 | 6 | 153 | 5 | 11850197 | ||
| Pubmed | 3.22e-11 | 7 | 153 | 5 | 15009097 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 3.22e-11 | 7 | 153 | 5 | 11163184 | |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 8.55e-11 | 8 | 153 | 5 | 19211612 | |
| Pubmed | 8.55e-11 | 8 | 153 | 5 | 10647776 | ||
| Pubmed | 8.55e-11 | 8 | 153 | 5 | 23804438 | ||
| Pubmed | 8.55e-11 | 8 | 153 | 5 | 10708949 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 1.92e-10 | 9 | 153 | 5 | 24932701 | |
| Pubmed | 1.92e-10 | 9 | 153 | 5 | 19018011 | ||
| Pubmed | 1.92e-10 | 9 | 153 | 5 | 9759503 | ||
| Pubmed | 1.92e-10 | 9 | 153 | 5 | 30134160 | ||
| Pubmed | 1.92e-10 | 9 | 153 | 5 | 24816837 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 1.92e-10 | 9 | 153 | 5 | 25155999 | |
| Pubmed | 1.92e-10 | 9 | 153 | 5 | 10708948 | ||
| Pubmed | 3.60e-10 | 4 | 153 | 4 | 17967875 | ||
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 3.82e-10 | 10 | 153 | 5 | 29247325 | |
| Pubmed | 3.82e-10 | 10 | 153 | 5 | 23620745 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 3.82e-10 | 10 | 153 | 5 | 29986157 | |
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 6.98e-10 | 11 | 153 | 5 | 27741240 | |
| Pubmed | 6.98e-10 | 11 | 153 | 5 | 24008158 | ||
| Pubmed | 1.19e-09 | 12 | 153 | 5 | 21538804 | ||
| Pubmed | 1.19e-09 | 12 | 153 | 5 | 14656760 | ||
| Pubmed | 1.19e-09 | 12 | 153 | 5 | 17460146 | ||
| Pubmed | 1.79e-09 | 5 | 153 | 4 | 15647271 | ||
| Pubmed | 1.79e-09 | 5 | 153 | 4 | 8673135 | ||
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 1.93e-09 | 13 | 153 | 5 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 1.93e-09 | 13 | 153 | 5 | 18329379 | |
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 1.93e-09 | 13 | 153 | 5 | 17628518 | |
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 2.99e-09 | 14 | 153 | 5 | 17670744 | |
| Pubmed | 2.99e-09 | 14 | 153 | 5 | 38951500 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 2.99e-09 | 14 | 153 | 5 | 33248111 | |
| Pubmed | 2.99e-09 | 14 | 153 | 5 | 16790475 | ||
| Pubmed | 2.99e-09 | 14 | 153 | 5 | 25274628 | ||
| Pubmed | 2.99e-09 | 14 | 153 | 5 | 23584254 | ||
| Pubmed | 2.99e-09 | 14 | 153 | 5 | 16435884 | ||
| Pubmed | 4.47e-09 | 15 | 153 | 5 | 23011393 | ||
| Pubmed | 4.47e-09 | 15 | 153 | 5 | 23946498 | ||
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 5.36e-09 | 6 | 153 | 4 | 18393632 | |
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 21518886 | ||
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 10400677 | ||
| Pubmed | Lack of the bone morphogenetic protein BMP6 induces massive iron overload. | 5.36e-09 | 6 | 153 | 4 | 19252488 | |
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 20042635 | ||
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 11169847 | ||
| Pubmed | 6.48e-09 | 16 | 153 | 5 | 21939397 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 1.25e-08 | 7 | 153 | 4 | 14699069 | |
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 10376010 | ||
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 18322278 | ||
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 12370310 | ||
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 15376321 | ||
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 1.25e-08 | 7 | 153 | 4 | 14580334 | |
| Pubmed | 1.25e-08 | 7 | 153 | 4 | 23933588 | ||
| Pubmed | 1.26e-08 | 18 | 153 | 5 | 23546880 | ||
| Pubmed | 1.26e-08 | 18 | 153 | 5 | 27720610 | ||
| Pubmed | 1.71e-08 | 19 | 153 | 5 | 23776616 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 2.27e-08 | 20 | 153 | 5 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 2.27e-08 | 20 | 153 | 5 | 32662771 | |
| Pubmed | 2.49e-08 | 8 | 153 | 4 | 12714599 | ||
| Pubmed | 2.49e-08 | 8 | 153 | 4 | 10531362 | ||
| Pubmed | Myocardial smad4 is essential for cardiogenesis in mouse embryos. | 3.82e-08 | 22 | 153 | 5 | 17585069 | |
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 26555259 | ||
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 15993878 | ||
| Pubmed | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. | 4.46e-08 | 9 | 153 | 4 | 14729481 | |
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 20007998 | ||
| Pubmed | 4.87e-08 | 23 | 153 | 5 | 30779601 | ||
| Pubmed | 4.87e-08 | 23 | 153 | 5 | 21937600 | ||
| Pubmed | 6.13e-08 | 24 | 153 | 5 | 34129836 | ||
| Pubmed | 6.13e-08 | 24 | 153 | 5 | 16943282 | ||
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 6.13e-08 | 24 | 153 | 5 | 26552887 | |
| Pubmed | 7.41e-08 | 10 | 153 | 4 | 15221015 | ||
| Pubmed | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. | 7.41e-08 | 10 | 153 | 4 | 9436979 | |
| Pubmed | SMAD 8 binding to mice Msx1 basal promoter is required for transcriptional activation. | 7.41e-08 | 10 | 153 | 4 | 16101586 | |
| Pubmed | 7.41e-08 | 10 | 153 | 4 | 22300732 | ||
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 7.41e-08 | 10 | 153 | 4 | 12543979 | |
| Pubmed | 7.64e-08 | 25 | 153 | 5 | 20019329 | ||
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 8.35e-08 | 3 | 153 | 3 | 30953749 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 21381028 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 24023003 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 31127639 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 28592488 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23384547 | ||
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 8.35e-08 | 3 | 153 | 3 | 16943440 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 27848974 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 22897816 | ||
| Pubmed | Blockade of Smad signaling by 3'-deoxyadenosine: a mechanism for its anti-fibrotic potential. | 8.35e-08 | 3 | 153 | 3 | 23439432 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 25165122 | ||
| Pubmed | Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. | 8.35e-08 | 3 | 153 | 3 | 18809571 | |
| Pubmed | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. | 9.42e-08 | 26 | 153 | 5 | 31311865 | |
| Pubmed | 1.40e-07 | 28 | 153 | 5 | 20346939 | ||
| Pubmed | Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. | 1.73e-07 | 12 | 153 | 4 | 15923624 | |
| Pubmed | 1.73e-07 | 12 | 153 | 4 | 30664861 | ||
| Pubmed | 2.39e-07 | 31 | 153 | 5 | 36445780 | ||
| Pubmed | 2.39e-07 | 31 | 153 | 5 | 25762570 | ||
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 2.50e-07 | 13 | 153 | 4 | 19914168 | |
| Pubmed | The non-canonical BMP and Wnt/β-catenin signaling pathways orchestrate early tooth development. | 2.82e-07 | 32 | 153 | 5 | 25428587 | |
| Pubmed | 3.32e-07 | 33 | 153 | 5 | 33436499 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 9111321 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 19247629 | ||
| Interaction | CYP11A1 interactions | 3.33e-07 | 9 | 147 | 4 | int:CYP11A1 | |
| Interaction | TOB1 interactions | 7.64e-07 | 44 | 147 | 6 | int:TOB1 | |
| Interaction | TRIM28 interactions | ZNF823 ZNF567 ZNF845 ZNF140 ZNF573 EPPK1 PFAS ZNF226 ZNF699 TRRAP ZNF181 ZNF440 GSPT1 TIPARP LRRC47 MEMO1 FANCD2 ZNF462 TRIM67 SIK2 ZNF808 ZNF420 ZNF701 ZNF761 ATM DCTN4 ZNF471 GCN1 SMAD2 | 7.84e-07 | 1474 | 147 | 29 | int:TRIM28 |
| Interaction | NOTCH2 interactions | ZNF823 ZNF787 FLT4 ZNF146 ZBTB17 ZSCAN26 ZNF362 ZNF865 ZNF32 ZNF341 DTX4 ZFP64 ZNF761 SMAD1 | 2.74e-06 | 423 | 147 | 14 | int:NOTCH2 |
| Interaction | SMAD5 interactions | 9.24e-06 | 101 | 147 | 7 | int:SMAD5 | |
| Interaction | HLA-B interactions | 1.05e-05 | 239 | 147 | 10 | int:HLA-B | |
| Interaction | SMAD9 interactions | 1.68e-05 | 153 | 147 | 8 | int:SMAD9 | |
| Interaction | CXXC5 interactions | 1.79e-05 | 22 | 147 | 4 | int:CXXC5 | |
| Interaction | OPALIN interactions | 2.34e-05 | 209 | 147 | 9 | int:OPALIN | |
| Interaction | MED24 interactions | 4.31e-05 | 128 | 147 | 7 | int:MED24 | |
| Interaction | ULK4 interactions | 4.85e-05 | 28 | 147 | 4 | int:ULK4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF787 KLK11 ZNF567 ZNF845 ZNF573 ZNF146 ZNF613 HIPK4 ZNF329 EML2 ZNF226 ZNF865 ZNF181 ZNF551 ZNF546 ZNF836 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 | 1.89e-12 | 1192 | 153 | 24 | chr19q13 |
| Cytoband | 1p35.1 | 3.97e-06 | 32 | 153 | 4 | 1p35.1 | |
| Cytoband | 19q13.41 | 6.68e-06 | 78 | 153 | 5 | 19q13.41 | |
| Cytoband | 19q13.43 | 2.13e-04 | 87 | 153 | 4 | 19q13.43 | |
| Cytoband | 9q34.11 | 7.52e-04 | 53 | 153 | 3 | 9q34.11 | |
| Cytoband | 22q11.23 | 7.52e-04 | 53 | 153 | 3 | 22q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 1.18e-03 | 137 | 153 | 4 | chr1p35 | |
| Cytoband | 19q13.12 | 1.83e-03 | 72 | 153 | 3 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF823 ZNF787 ZNF502 ZNF567 ZNF845 ZNF140 ZNF573 ZNF146 ZNF613 ZBTB17 ZNF329 ZSCAN26 GLIS3 ZBTB8A ZKSCAN7 ZNF362 ZNF226 ZNF699 ZNF865 ZNF181 ZNF440 ZNF551 ZNF546 RLF ZNF462 ZBTB49 ZNF630 ZNF836 ZNF32 ZNF852 ZNF341 ZFP64 ZNF70 ZNF534 ZNF808 ZNF420 ZNF701 ZNF761 ZNF528 ZNF83 ZNF471 GLIS1 | 2.03e-29 | 718 | 116 | 42 | 28 |
| GeneFamily | SMAD family | 5.50e-10 | 8 | 116 | 5 | 750 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | ZNF146 ATR WDR7 RCHY1 ZNF329 SMPD4 PFAS ZNF226 TRRAP ZNF32 ZFP64 ATM MERTK IL27RA | 7.98e-07 | 477 | 152 | 14 | M40930 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-06 | 171 | 153 | 7 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 175 | 153 | 7 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.79e-06 | 193 | 153 | 7 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.79e-06 | 193 | 153 | 7 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 128 | 153 | 6 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 1.29e-05 | 149 | 153 | 6 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-05 | 161 | 153 | 6 | 46b5d80d2d521fb69752aba4c10383e715a32002 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-05 | 166 | 153 | 6 | a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9 | |
| ToppCell | Ionocyte-iono-3|World / Class top | 2.38e-05 | 166 | 153 | 6 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 2.46e-05 | 167 | 153 | 6 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | ASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.72e-05 | 170 | 153 | 6 | 84705434234bf2fbb5256bd5a1f6ab54c01c5a51 | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 2.90e-05 | 172 | 153 | 6 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.20e-05 | 175 | 153 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 176 | 153 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-05 | 177 | 153 | 6 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.63e-05 | 179 | 153 | 6 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.63e-05 | 179 | 153 | 6 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-05 | 181 | 153 | 6 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-05 | 181 | 153 | 6 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-05 | 181 | 153 | 6 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 185 | 153 | 6 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.36e-05 | 185 | 153 | 6 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.36e-05 | 185 | 153 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.36e-05 | 185 | 153 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 185 | 153 | 6 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-05 | 187 | 153 | 6 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.63e-05 | 187 | 153 | 6 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 4.77e-05 | 188 | 153 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 188 | 153 | 6 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.77e-05 | 188 | 153 | 6 | 1aecae0d94905bfbd414adf1450035e5b863abe7 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 188 | 153 | 6 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 188 | 153 | 6 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-05 | 188 | 153 | 6 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-05 | 188 | 153 | 6 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.91e-05 | 189 | 153 | 6 | eb5b107dbc50e538dc27ba2867b196a23a8054bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 189 | 153 | 6 | c6760ea8ecca6abdd9eb067f3b3f4eea9420b852 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.91e-05 | 189 | 153 | 6 | af5f92dc3b3bc6acacd633981b8ef7f0c593c92e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-05 | 189 | 153 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-05 | 189 | 153 | 6 | 04bdcf05b8c72c13e7d35d1c7444f50374d41203 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 190 | 153 | 6 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.05e-05 | 190 | 153 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.05e-05 | 190 | 153 | 6 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.05e-05 | 190 | 153 | 6 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 5.05e-05 | 190 | 153 | 6 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 190 | 153 | 6 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 190 | 153 | 6 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.05e-05 | 190 | 153 | 6 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 191 | 153 | 6 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 191 | 153 | 6 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 5.36e-05 | 192 | 153 | 6 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 5.36e-05 | 192 | 153 | 6 | cbc304c704e8524eee24a1619d0fbb2cf96c4976 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.36e-05 | 192 | 153 | 6 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.67e-05 | 194 | 153 | 6 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.67e-05 | 194 | 153 | 6 | e72be6dc2711c1d4f16943c8615cf9dc2e961ff3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.67e-05 | 194 | 153 | 6 | ac03be73fdc32dacd4a450c0fb28617e043b8444 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.67e-05 | 194 | 153 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.67e-05 | 194 | 153 | 6 | 7ab4418a8a12c488d74af3676bdac672628da80c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.67e-05 | 194 | 153 | 6 | 760761ce7d22edf9a8cec71e8ab0caa273fce3f7 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 5.84e-05 | 195 | 153 | 6 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-05 | 195 | 153 | 6 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.01e-05 | 196 | 153 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.01e-05 | 196 | 153 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.01e-05 | 196 | 153 | 6 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.01e-05 | 196 | 153 | 6 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.01e-05 | 196 | 153 | 6 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.01e-05 | 196 | 153 | 6 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.18e-05 | 197 | 153 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.18e-05 | 197 | 153 | 6 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 198 | 153 | 6 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.35e-05 | 198 | 153 | 6 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 198 | 153 | 6 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 198 | 153 | 6 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.53e-05 | 199 | 153 | 6 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.53e-05 | 199 | 153 | 6 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.53e-05 | 199 | 153 | 6 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.71e-05 | 200 | 153 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.71e-05 | 200 | 153 | 6 | 7751affe353a5208ffad7a58308c588050e77243 | |
| ToppCell | P15-Hematopoietic-Erythroid-enucleate_erythrocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.97e-05 | 64 | 153 | 4 | 0c000ac0f2344684ed06e27db3c9415e332a079f | |
| ToppCell | P15-Hematopoietic-Erythroid|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.97e-05 | 64 | 153 | 4 | 76f10b5420b88ad5260e5e9da656cac3875284da | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-05 | 131 | 153 | 5 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.36e-05 | 69 | 153 | 4 | 54e5ede00ce2920158d1cc0ac8e718aa24a4342e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.36e-05 | 69 | 153 | 4 | c93a47ee777b560f69b705d5d597f3cb3a3f558a | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.36e-05 | 69 | 153 | 4 | 8946d7e433c232c56563a6c464152c0a8cdbdf92 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 140 | 153 | 5 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 142 | 153 | 5 | d60d2a5d0876a552bc161fc4e2dfe180f88f03a5 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 148 | 153 | 5 | 1d9fa6b2ee9feaed39c63d44e638b5c0942d947c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 150 | 153 | 5 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 151 | 153 | 5 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 83 | 153 | 4 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 83 | 153 | 4 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 83 | 153 | 4 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 83 | 153 | 4 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-04 | 156 | 153 | 5 | 7ece590fd8f29382e349dd0e5e016d2926aeb518 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-04 | 157 | 153 | 5 | 0a552abfd139afc8516c38ca568f9922511dddce | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 159 | 153 | 5 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 161 | 153 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| Drug | 1,3,2-dioxaborolan-2-ol | 6.09e-06 | 104 | 151 | 7 | CID005289333 | |
| Drug | lanthanum carbide | 6.67e-06 | 19 | 151 | 4 | CID000123280 | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 6830_DN | |
| Drug | 5-methoxypsoralen | 9.82e-06 | 7 | 151 | 3 | ctd:C022909 | |
| Drug | M 5026 | 1.49e-05 | 23 | 151 | 4 | CID000092852 | |
| Drug | LDN 193189 | 1.56e-05 | 8 | 151 | 3 | ctd:C554430 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.36e-05 | 176 | 151 | 8 | 6784_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.46e-05 | 177 | 151 | 8 | 3177_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.56e-05 | 178 | 151 | 8 | 4710_DN | |
| Drug | LY2109761 | 3.32e-05 | 10 | 151 | 3 | ctd:C530108 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 2.40e-05 | 2 | 145 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.21e-05 | 13 | 145 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | beta-hydroxybutyric acid measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0010465 | |
| Disease | Aplastic Anemia | 4.96e-04 | 7 | 145 | 2 | C0002874 | |
| Disease | Hypoplastic anemia | 4.96e-04 | 7 | 145 | 2 | C0178416 | |
| Disease | Loeys-Dietz Syndrome | 4.96e-04 | 7 | 145 | 2 | C2697932 | |
| Disease | Idiopathic pulmonary hypertension | 8.44e-04 | 9 | 145 | 2 | C0152171 | |
| Disease | Uterine Neoplasms | 8.44e-04 | 9 | 145 | 2 | C0042138 | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 8.44e-04 | 9 | 145 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 1.05e-03 | 10 | 145 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | Uterine Cancer | 1.05e-03 | 10 | 145 | 2 | C0153567 | |
| Disease | Adenoid Cystic Carcinoma | 1.52e-03 | 100 | 145 | 4 | C0010606 | |
| Disease | Pneumoconiosis | 2.10e-03 | 14 | 145 | 2 | C0032273 | |
| Disease | Bagassosis | 2.10e-03 | 14 | 145 | 2 | C0004681 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 2.10e-03 | 14 | 145 | 2 | C1150929 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.27e-03 | 53 | 145 | 3 | C4707243 | |
| Disease | leukemia | 2.53e-03 | 55 | 145 | 3 | C0023418 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.75e-03 | 16 | 145 | 2 | C3203102 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2.75e-03 | 16 | 145 | 2 | C0334634 | |
| Disease | Withdrawal Symptoms | 2.94e-03 | 58 | 145 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.94e-03 | 58 | 145 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.94e-03 | 58 | 145 | 3 | C0038587 | |
| Disease | Benign neoplasm of stomach | 3.11e-03 | 17 | 145 | 2 | C0153943 | |
| Disease | Familial primary pulmonary hypertension | 3.11e-03 | 17 | 145 | 2 | C0340543 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.11e-03 | 17 | 145 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.11e-03 | 17 | 145 | 2 | C0154060 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 3.56e-03 | 62 | 145 | 3 | EFO_0004616, EFO_1000786 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.88e-03 | 19 | 145 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Low Grade Lymphoma (neoplasm) | 4.74e-03 | 21 | 145 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 4.74e-03 | 21 | 145 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 4.74e-03 | 21 | 145 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 4.74e-03 | 21 | 145 | 2 | C0079757 | |
| Disease | Left Ventricle Remodeling | 4.74e-03 | 21 | 145 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 4.74e-03 | 21 | 145 | 2 | C0600519 | |
| Disease | Lymphoma, Undifferentiated | 4.74e-03 | 21 | 145 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 4.74e-03 | 21 | 145 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 4.74e-03 | 21 | 145 | 2 | C0024304 | |
| Disease | Lymphoma, Diffuse | 4.74e-03 | 21 | 145 | 2 | C3714542 | |
| Disease | Stomach Carcinoma | 4.74e-03 | 21 | 145 | 2 | C0699791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GCHCLTLLHVPIDVY | 101 | H3BQW9 | |
| DHKISHLGTPLYLAC | 161 | Q96DX5 | |
| IRYHCKDGFIQRHLP | 3321 | P13611 | |
| TRKLHHPANYLICSL | 51 | P30939 | |
| LKALAVCHGPLDHYD | 66 | Q8WV93 | |
| VHGSHCSKYRLARIP | 916 | Q5VU97 | |
| VCLHYKGREAIHPLL | 316 | Q8IYT2 | |
| KRHYRCALIALEHGA | 126 | Q9NU02 | |
| VGDLILAHLHKKCPY | 516 | Q53GS7 | |
| LQHLCRPHGTIYLAS | 166 | Q96AZ1 | |
| LRLKHCLAYVLHTSG | 186 | Q4L235 | |
| EKHHVSVRLGYGCLL | 1791 | Q96M86 | |
| LAVLVHKHYGPRLKC | 686 | Q9HBB8 | |
| LARLVTVYCEHGHKA | 56 | Q96HY7 | |
| PDLVGKLSRCGHVYH | 431 | Q9Y2E6 | |
| VGPSILHCRVLHVDY | 266 | Q8TBH0 | |
| QKHCERRHGPLSKLY | 96 | Q5T6C5 | |
| LLVLELHPKGSLCHY | 276 | Q16671 | |
| YIGHLTTLCHDRDPL | 1026 | Q8IUD2 | |
| CIYGRDCLKHHTVLP | 251 | Q7Z3E1 | |
| ALCIHERYHSVLQPL | 16 | P14920 | |
| GPHLHLSGNCYLKIT | 876 | Q6ZRR7 | |
| VAAHCGHYRVTKLLL | 371 | Q01484 | |
| HYLLTHLPAVALCPA | 96 | A6NCF5 | |
| KLLSHDLPHYVALCF | 76 | Q14667 | |
| IHIGSQPGKHLCVYL | 3196 | Q16787 | |
| YLHMSHGKCPLLVRG | 6 | Q8NA97 | |
| DYLLHGHRLKQPEDC | 811 | Q12866 | |
| YICETQGLPKPHLLH | 226 | Q8NE63 | |
| GSYALCLLHEGKVLH | 201 | P43405 | |
| GTHYRAYLLKCHELP | 251 | Q9BZ67 | |
| ATHELRAVKGPLLYC | 376 | Q8N1G4 | |
| TGHTEKICSLRFHPL | 591 | P57737 | |
| HKSIICPGYNAVLHI | 531 | Q8IYD1 | |
| VVKTLTRHHLYCEPP | 1426 | O43157 | |
| VHRFGKHVPCYIHVL | 261 | Q9H344 | |
| HLKFRYHARCLPHLG | 516 | P14222 | |
| LATSGRCYHLRHKVL | 536 | Q6UWB1 | |
| TAAHCLKPRYIVHLG | 91 | Q9UBX7 | |
| DKICRQLIYHLTPHS | 111 | Q2VPJ9 | |
| LHLAEVCHRQYPKVP | 131 | P49281 | |
| FPHTRLGKLLTCHSE | 36 | Q9BQ31 | |
| YVVHVLPHLLLCFGD | 1456 | Q92616 | |
| GLLAPLACHRLLHSY | 36 | Q9BRR3 | |
| DIRHCYSIQHCPLKG | 366 | P27918 | |
| EHKSIICPGYNAVLH | 401 | P15170 | |
| CRYHLTEPGLASRHL | 776 | Q9NXE4 | |
| LHRHGCEKPLGFYIR | 161 | Q9BYG4 | |
| LTCISVHRYLGICHP | 126 | P51582 | |
| LLGHCLLVTLARHYP | 101 | P09105 | |
| CYKVLIPHLVIRSHF | 1251 | Q13315 | |
| AKGSHPVHCVLFLAL | 91 | Q08828 | |
| KGDLVPFALLHLLHC | 881 | Q13535 | |
| HLRPALLKINELCYH | 311 | Q9C0G6 | |
| GLKCLHHTYRRGLRV | 146 | Q99819 | |
| KAPLRGTLLCTYVIH | 146 | P57773 | |
| YVHRVLAHELLCPQG | 911 | Q5T0N1 | |
| IHLRSHTGEKPYLCQ | 431 | Q8NEA6 | |
| PCLSELHKAYLDIPH | 421 | P78396 | |
| VRKHICTGPHAFLLV | 316 | Q8ND71 | |
| PCSRIAHIERAHKPY | 376 | Q6P9A2 | |
| HKEGKLLPLVHQCYL | 141 | Q9NS18 | |
| TEIPLHYICKLATHA | 156 | O75072 | |
| LRKVSHYLPHLRVAC | 291 | O75426 | |
| TYKLCHPEELVLLGH | 71 | P09919 | |
| HNALRIHSYPEGICL | 271 | Q9BZJ6 | |
| YLGHNDDIKCLAIHP | 101 | O95834 | |
| PVCRPTHVHEYKLTA | 106 | P19447 | |
| YNKLLEFVPHHCRLL | 276 | Q14746 | |
| IHLRSHTGEKPYLCQ | 281 | Q8NBF1 | |
| LCEKHGDRVPLSLHL | 1566 | Q9BYK8 | |
| PVCASQLYPRHKHLL | 256 | Q9UJW0 | |
| IIRVPAPCHYAHKLA | 846 | Q7Z3Z3 | |
| LKTCHPQYCHLGRDV | 266 | A6NIM6 | |
| SDTHLLYIIHGPICA | 286 | Q16602 | |
| DSHPVLHVCLKYGRL | 1286 | Q9BXW9 | |
| ALHLRIHTGKKPYQC | 256 | Q15072 | |
| LKKYHNTICGRHPIG | 236 | Q9Y316 | |
| HPVREGHCYKLVSII | 281 | Q75VX8 | |
| LIGKPALQALLYHCH | 1471 | Q86VV8 | |
| AGLALVPRKLCAHYT | 801 | Q15031 | |
| PLETAYRRGCLHKDI | 2026 | P58107 | |
| LLHHGSYIKLGCLQF | 946 | Q96QT6 | |
| DKLRVLPCAHAYHSR | 241 | Q9H6Y7 | |
| ILSAVDYCHGRKIVH | 126 | Q9H0K1 | |
| EGKDCLQGLRLRHHY | 1151 | Q9Y2G9 | |
| YTHKSPRVHSLILCN | 121 | Q9NZD8 | |
| SPYHLQGKREKLHCR | 91 | Q8TBB0 | |
| KDCLYLIHIGLSHEV | 211 | Q7L1T6 | |
| QHPILCLHLLKVLYS | 706 | Q9NRP7 | |
| VSHRKGLPHVIYCRV | 81 | O15198 | |
| LQVSHRKGLPHVIYC | 76 | Q99717 | |
| QVSHRKGLPHVIYCR | 76 | Q15797 | |
| SYLTCHRRLHTGEKP | 676 | Q96IR2 | |
| SGLHIIAACNPYRKH | 2516 | Q63HN8 | |
| RLGHPCFYHQKDIKL | 111 | Q8N1K5 | |
| SLHQRIHTGEKPYIC | 381 | Q8N184 | |
| CLLRHERIHTGEKPY | 541 | P16415 | |
| GKAFHCLRLYLIHER | 206 | Q8IYI8 | |
| PVCYLCLEEGRHAKH | 321 | Q6ZTA4 | |
| SRHKYLKDHRCRLGP | 721 | Q9BYN7 | |
| SLTCHRRLHTGEKPY | 396 | Q86XN6 | |
| HVKTHSADLLRLPCG | 396 | P0CJ78 | |
| LCRLTHIPAYKVSGD | 336 | Q7Z7L7 | |
| DLKRHLRCHTGERPY | 296 | Q96BR9 | |
| LLHQRIHKGGKPYEC | 346 | Q86YE8 | |
| ALKHYLTPRSEPHCL | 91 | Q9Y5T5 | |
| CGELALKQLHYLRPV | 1871 | Q13129 | |
| LRYHLPGLSEKITCA | 396 | Q6IEE8 | |
| QVSHRKGLPHVIYCR | 116 | Q15796 | |
| QVSHRKGLPHVIYCR | 76 | P84022 | |
| KRYRDAGLHCLELGH | 966 | O15067 | |
| HIPAHLTYGKLLALT | 676 | Q8N394 | |
| PECLQRAVHGLLHYL | 46 | Q9NPG8 | |
| TYRHGEKLIITCHEG | 136 | Q5VX71 | |
| GTDARPYCKVLLLHE | 86 | P35916 | |
| LHLRTHTGEIPYECK | 486 | Q86UE3 | |
| LHKIIHTGERPYECS | 296 | Q7Z340 | |
| SLVCHRRIHSGEKPY | 721 | Q8N4W9 | |
| HLLIHTGEKPYECID | 441 | Q76KX8 | |
| LGHKYLNLAVPIHSC | 121 | Q6ZUG5 | |
| IIHLRVHTGEKPYEC | 531 | Q2M218 | |
| DLKIHCRIHTGEKPY | 601 | Q9NYT6 | |
| LEHLRIHTGEKPYLC | 326 | Q16670 | |
| RHLRIHSGEKPYVCI | 491 | Q13105 | |
| CLIRHQSLHTGEKPY | 341 | Q6ZMS4 | |
| LRHLVIHTGEKPYEC | 156 | Q9UC06 | |
| ILHRRIHTGEKPYKC | 391 | Q9BX82 | |
| CLIRHQRSHTGEKPY | 421 | Q8TBZ5 | |
| LIHRRTHTGEKPYVC | 416 | Q6PF04 | |
| ILHQRTHTGEKPYVC | 401 | P52738 | |
| AQHLRIHLGVKPYHC | 271 | Q5T0B9 | |
| HRIHIGEKPYKCTLC | 596 | Q3MIS6 | |
| LCPYTHGTLEKLKIH | 1581 | Q96JM2 | |
| CLIRHQRLHTGEKPY | 621 | Q9P0L1 | |
| ILHHRIHTGEKPYKC | 211 | Q8TAQ5 | |
| HLRRHSGEKPYICEI | 441 | Q6ZSB9 | |
| VLPCGHLLHRTCYEE | 161 | Q96PM5 | |
| FLQKPHLCYRDLHSA | 216 | Q8NEE8 | |
| LACHRRLHTGEKPYK | 491 | Q9NV72 | |
| IIHIRIHTGEKPYEC | 351 | Q32M78 | |
| IHVGESLYAIVLCKH | 71 | Q8TBM7 | |
| EGRLLCHGHYPEILV | 126 | Q9Y4E6 | |
| TVHLRIHTGEKPYEC | 331 | Q86UD4 | |
| DPACKYSGHLLLAHI | 1876 | Q9Y4A5 | |
| HLRIHSDERPYKCQL | 376 | Q9NTW7 | |
| SYKCHSVEIPEHGLI | 186 | Q6X784 | |
| CLARHLRIHTGQKPY | 596 | Q6ZNA1 | |
| VHIRVHTGLKPYACT | 206 | P17041 | |
| HLRNHIRLKPYECSI | 451 | Q2M3W8 | |
| HLIIHTGEKPYRCNV | 251 | P51522 | |
| QHLLPASYCDLLHKA | 336 | Q9GZU3 | |
| HLHKLGILFCDISPR | 111 | Q96C45 | |
| QHRRIHTGEKPYACL | 111 | Q6DD87 | |
| EAHLCLKRHYAAFPL | 606 | P23276 |